Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)

NCT03073603 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

259

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Discontinuation of disease modifying therapy
DRUG: Standard of Care

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]
[object Object]